Iloprost
- Generic Name
- Iloprost
- Brand Names
- Ventavis
- Drug Type
- Small Molecule
- Chemical Formula
- C22H32O4
- CAS Number
- 78919-13-8
- Unique Ingredient Identifier
- JED5K35YGL
Overview
Iloprost is a synthetic analogue of prostacyclin PGI2 that dilates systemic and pulmonary arterial vascular beds. It is used to treat pulmonary arterial hypertension (PAH).
Background
Iloprost is a synthetic analogue of prostacyclin PGI2 that dilates systemic and pulmonary arterial vascular beds. It is used to treat pulmonary arterial hypertension (PAH).
Indication
Used for the treatment of pulmonary arterial hypertension.
Associated Conditions
- NYHA class III Pulmonary arterial hypertension
- NYHA class IV Pulmonary arterial hypertension
Clinical Trials
FDA Approved Products
VENTAVIS
Manufacturer:Actelion Pharmaceuticals US, Inc.
Route:RESPIRATORY (INHALATION)
Strength:20 ug in 1 mL
Approved: 2022/03/09
NDC:66215-303
VENTAVIS
Manufacturer:Actelion Pharmaceuticals US, Inc.
Route:RESPIRATORY (INHALATION)
Strength:10 ug in 1 mL
Approved: 2022/03/09
NDC:66215-302
Singapore Approved Products
VENTAVIS SOLUTION FOR INHALATION
Manufacturer:BERLIMED SA
Form:SOLUTION
Strength:0.010 mg/ml
Online:Yes
Approved: 2005/07/06
Approval:SIN13140P
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath